All In MedTech

FDA Clearance Tracker · P170003-S008

Lutonix 035 Drug Coated Balloon PTA Catheter

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 24, 2019 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 24, 2019

Approved

Time to decision

60 days

Received Apr 25, 2019. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P170003-S008
Device name
Lutonix 035 Drug Coated Balloon PTA Catheter
Applicant
Lutonix
Applicant location
New Hope, MN
Received
Apr 25, 2019
Decided
Jun 24, 2019
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P170003

Device type

Device class
Class III

Every decision under product code PRC

FDA's approval statement

As written in FDA's record.

Approval of the changes to the Informed Consent Form for the New Enrollment PAS Registry.

Source documents

Other decisions for Lutonix

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.